Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Abstract Background Most international guidelines recommend triple-therapy regimens consisting of a proton pump inhibitor, clarithromycin, and amoxicillin/metronidazole for at least 7 days for the eradication of Helicobacter pylori. However, the efficacy of 7-day clarithromycin-based standard triple...

Full description

Bibliographic Details
Main Authors: Hyuk Lee, Beom Jin Kim, Sang Gyun Kim, Jin Il Kim, Il Ju Choi, Yong Chan Lee, Jae G. Kim, Jae J. Kim, Korean College of Helicobacter and Upper Gastrointestinal Research
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Trials
Subjects:
Helicobacter pylori
Triple therapy
Concomitant therapy
Sequential therapy
Online Access:http://link.springer.com/article/10.1186/s13063-017-2281-0

Internet

http://link.springer.com/article/10.1186/s13063-017-2281-0

Similar Items